531 related articles for article (PubMed ID: 26418878)
1. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
[TBL] [Abstract][Full Text] [Related]
2. The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4.
Jin R; Liu W; Menezes S; Yue F; Zheng M; Kovacevic Z; Richardson DR
J Cell Sci; 2014 Jul; 127(Pt 14):3116-30. PubMed ID: 24829151
[TBL] [Abstract][Full Text] [Related]
3. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
4. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract][Full Text] [Related]
5. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
[TBL] [Abstract][Full Text] [Related]
7. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
[TBL] [Abstract][Full Text] [Related]
8. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
[TBL] [Abstract][Full Text] [Related]
9. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
10. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
12. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
13. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
[TBL] [Abstract][Full Text] [Related]
14. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
15. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
16. The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells.
Mi L; Zhu F; Yang X; Lu J; Zheng Y; Zhao Q; Wen X; Lu A; Wang M; Zheng M; Ji J; Sun J
Oncogene; 2017 Jul; 36(30):4323-4335. PubMed ID: 28346422
[TBL] [Abstract][Full Text] [Related]
17. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
[TBL] [Abstract][Full Text] [Related]
19. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
20. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]